MedPath

Study of Application of Tilashtaka Ghrita in the Treatment of Dushta Avastha of Vrana

Phase 2
Conditions
Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Registration Number
CTRI/2020/10/028187
Lead Sponsor
Meera Nagre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Wound length 3 to 15 cm

Patients with fulfilled screening criteria

Wounds up to muscle

Exclusion Criteria

Patients suffering from major illness like cirrhosis liver disorder or Ascitis or Renal Failure or DM or Tuberculosis or AIDS or HIV syndrome

Patient with malignancy

Bleeding Disorder

Multiple Ulcer(more than three)

Arterial Ulcers

T.A.O.

Leprotic ulcers

Gonorrheal ulcers

Syphilitic ulcers

Vranas situated over Asthi and Sandhi and Koshta and Marma Adhisthana

Age Group <18year and >60 years old

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To find out the efficacy of Tilashtak Ghrita in decreasing healing time of Dushta Avastha of vranaTimepoint: 14 days
Secondary Outcome Measures
NameTimeMethod
To compare the effects of local application of Tilashtak ghrita and povidone iodine ointment in dushta avastha of vrana <br/ ><br>To Standardize Tilashtak ghrita <br/ ><br> <br/ ><br>Timepoint: 14 days
© Copyright 2025. All Rights Reserved by MedPath